Cancer Treatment – Combination

Cancer Treatment – Combination Therapy at RCERT

Cancer is one of the leading causes of death globally, with millions of new cases diagnosed each year. As medical science evolves, it has become clear that a single treatment approach is often not enough to effectively combat cancer. That’s why combination cancer therapy — using multiple treatment modalities together — has become a standard in modern oncology.

At RCERT (Regional Cell Research & Therapy Centre), we embrace a multi-pronged, personalized cancer treatment strategy that integrates cutting-edge cell therapy with conventional and supportive treatments to achieve better outcomes and reduce relapse rates.

🔬 What Is Combination Cancer Therapy?

Combination therapy involves the use of two or more therapeutic approaches to treat cancer. These may include:

Chemotherapy
Radiation therapy
Surgery
Targeted therapy
Immunotherapy (e.g., cell-based therapies)
Hormonal therapy
Regenerative and supportive care

At RCERT, the focus is on integrating immunotherapy and regenerative medicine with conventional methods to enhance the body’s natural ability to fight cancer and recover from treatment.

🧬 Why Combination Therapy Works

Cancer is a complex, adaptive disease that often mutates to resist single-treatment strategies. Combining therapies provides multiple advantages:

Targets cancer from multiple angles
Reduces resistance and relapse risk
Enhances immune activation
Improves survival rates and treatment outcomes
Minimizes side effects when balanced properly

The idea is not just to kill cancer cells — but to train the body to keep fighting and stay resilient.

🧪 RCERT’s Approach to Combination Cancer Therapy

RCERT specializes in cell-based and immune-enhancing therapies that are designed to work in harmony with standard cancer treatments.

Our cancer treatment combination protocols may include:

1️⃣ Dendritic Cell (DC) Therapy

DCs present tumor antigens to T cells, “teaching” the immune system to attack cancer cells specifically.

2️⃣ Cytokine-Induced Killer (CIK) Cells

CIK cells are immune effector cells that can kill cancer cells broadly and effectively, even without MHC compatibility.

3️⃣ Natural Killer (NK) Cells

NK cells provide fast-acting cytotoxic effects on cancer cells, especially useful in solid tumors.

4️⃣ DC-CIK Combination Therapy

This method combines DC precision and CIK cytotoxicity for enhanced tumor targeting and immune response.

5️⃣ DC-CTL Therapy

Dendritic Cells stimulate the production of Cytotoxic T Lymphocytes (CTLs), which recognize and destroy tumor-specific antigens.

6️⃣ Mesenchymal Stem Cells (MSC) & Exosome Support

Used to manage inflammation, support tissue regeneration, and improve quality of life during or after cancer therapy.

🧠 When Is Combination Therapy Recommended?

Combination therapy is often used in the following scenarios:

Advanced-stage cancers
Treatment-resistant tumors
After relapse or recurrence
As maintenance therapy post-surgery or chemotherapy
As part of clinical trials or personalized therapy programs

RCERT evaluates each patient’s medical history, cancer type, biomarkers, and immune profile before designing a combination therapy plan.

📈 Evidence-Based Outcomes

International and regional studies have shown that patients who undergo combination immunotherapy experience:

Improved progression-free survival (PFS)
Increased overall response rate (ORR)
Reduced recurrence
Enhanced immune markers
Better tolerance and quality of life

RCERT’s clinical protocols follow GMP standards, are ethically reviewed, and are supported by international research collaborations with institutions such as UNIMAS and Zhongrong Cell Technology Center (China).

💡 Real-World Example of RCERT Cancer Treatment Plan

Case Example: Nasopharyngeal Carcinoma (NPC)

Initial Diagnosis
→ Conventional staging and biopsy confirm NPC.
Primary Treatment
→ Radiation + Chemotherapy.
Post-Chemo Evaluation
→ Blood test shows suppressed immunity; cancer markers decline but risk of recurrence remains.
RCERT Cell Therapy Integration
→ DC-CIK therapy + MSC infusion over 4–6 weeks.
Outcome
→ Patient reports improved energy, appetite, immune function. Follow-up scans remain clear.

🩺 What to Expect During RCERT Combination Therapy

Step 1: Consultation
Clinical evaluation, blood tests, imaging review.
Step 2: Custom Protocol Design
Based on patient’s cancer type, stage, immune status, and treatment history.
Step 3: Cell Therapy Preparation
Cells are harvested (e.g., via blood draw), cultured, activated, and expanded in RCERT’s GMP lab.
Step 4: Therapy Administration
Infusions delivered under supervision at our clinical centre.
Step 5: Monitoring
Regular lab work, imaging, and consultation to track response.

⚖️ Is Combination Therapy Safe?

Yes — especially when cell-based therapies are conducted in certified clinical environments.

Common benefits of RCERT protocols:

Minimal systemic toxicity
No hair loss or nausea (unlike chemo)
Boosts immune function instead of suppressing it
May reduce side effects of conventional treatments

Mild side effects may include:

Temporary fatigue
Mild fever post-infusion
Local injection site discomfort

🎯 Who Is Suitable for RCERT Combination Therapy?

Combination therapy at RCERT may be ideal for:

Patients with solid tumors or hematological cancers
Individuals who have completed or failed chemotherapy/radiation
Patients with relapsed or recurrent cancer
Individuals seeking non-toxic, immune-based cancer support
Participants in clinical trials or integrative oncology programs

🌍 The Future of Cancer Combination Therapy at RCERT

With cancer becoming increasingly complex and treatment-resistant, RCERT is committed to:

Expanding multi-modal therapy options for Malaysian and ASEAN patients
Partnering with local hospitals to co-manage advanced cases
Conducting research on next-gen therapy combinations, including CAR-T, MSC-Exosome platforms, and AI-driven diagnostics
Incorporating genomic profiling, DNA methylation, and immune aging markers into personalized cancer care

📝 Conclusion

Cancer treatment is no longer one-size-fits-all. At RCERT, our combination therapy approach is designed to outsmart cancer by blending the power of immunotherapy, regenerative medicine, and personalized care.

Whether you’re fighting a current diagnosis, recovering from treatment, or aiming to reduce relapse risk, RCERT offers a scientifically sound, patient-centered path forward.

📞 Ready to explore your options?
Contact RCERT today to schedule your consultation and begin your customized cancer care journey.

Contact us